{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22381221",
  "DateCompleted": {
    "Year": "2013",
    "Month": "05",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ajic.2012.01.001"
    ],
    "Journal": {
      "ISSN": "1527-3296",
      "JournalIssue": {
        "Volume": "40",
        "Issue": "2",
        "PubDate": {
          "Year": "2012",
          "Month": "Mar"
        }
      },
      "Title": "American journal of infection control",
      "ISOAbbreviation": "Am J Infect Control"
    },
    "ArticleTitle": "Antimicrobial stewardship: a collaborative partnership between infection preventionists and health care epidemiologists.",
    "Pagination": {
      "StartPage": "94",
      "EndPage": "95",
      "MedlinePgn": "94-5"
    },
    "Abstract": {
      "AbstractText": [
        "It is clear that the widespread and injudicious use of antimicrobials has greatly increased the presence of MDROs that threaten the health of all. There is worldwide acknowledgement that this threat is growing, and that prudent use of antimicrobials combined with infection prevention can prevent harm and improve patient safety. Antimicrobial stewardship programs must harness the talents of all members of the health care team to effectively identify the organism, determine its susceptibility, institute any precautions required, and prescribe the narrowest-acting antibiotic that will destroy it. IPs/HEs play a pivotal role in this approach, by assisting with early organism and infected patient identification, by promoting compliance with standard and transmission-based precautions and other infection prevention strategies such as care bundle practices, hand hygiene, and by educating staff, patients, and visitors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Workgroup Chair, HCA, Inc., Nashville, TN, USA. Julia.Moody@hcahealthcare.com"
          }
        ],
        "LastName": "Moody",
        "ForeName": "Julia",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cosgrove",
        "ForeName": "Sara E",
        "Initials": "SE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Olmsted",
        "ForeName": "Russell",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Septimus",
        "ForeName": "Edward",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Aureden",
        "ForeName": "Kathy",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Oriola",
        "ForeName": "Shannon",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Patel",
        "ForeName": "Gita Wasan",
        "Initials": "GW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Trivedi",
        "ForeName": "Kavita K",
        "Initials": "KK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Infect Control",
    "NlmUniqueID": "8004854",
    "ISSNLinking": "0196-6553"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prescription Drugs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "adverse effects"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [
        "legislation & jurisprudence",
        "organization & administration"
      ],
      "DescriptorName": "Communicable Disease Control"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Drug Resistance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "organization & administration"
      ],
      "DescriptorName": "Infection Control Practitioners"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Interprofessional Relations"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology",
        "prevention & control"
      ],
      "DescriptorName": "Mycoses"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "adverse effects"
      ],
      "DescriptorName": "Prescription Drugs"
    },
    {
      "QualifierName": [
        "legislation & jurisprudence",
        "standards"
      ],
      "DescriptorName": "Public Health"
    },
    {
      "QualifierName": [
        "drug therapy",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Virus Diseases"
    }
  ]
}